Dysregulation of splicing-related proteins in prostate cancer is controlled by FOXA1
J. G. Foster, R. Arkell, M. Del Giudice, C. Anene, A. Lauria, J. D. G. Kelly, N. R. Lemoine, S. Oliviero, M. Cereda, P. Rajan
This study identifies FOXA1 as a key regulator of splicing-related proteins in prostate cancer, linking its dysregulation to poor patient outcomes and suggesting therapeutic targeting of splicing pathways.
bioRxiv · Dec 31, 2018 · PreprintCancer Biology